Results demonstrated that compared to sh‐NC treatment, expression levels of SLC39A14 and N‐cadherin were decreased while E‐cadherin expression was increased in the mice with sh‐circ_001842 (all P < .05), which also manifested lower cell migration ability and inhibited tumour deterioration (Figure 6D‐F). The gene discussed is SLC39A14; the disease is neoplasm.